Ameriprise price target raised to $392 from $360 at Piper Sandler

Piper Sandler raised the firm’s price target on Ameriprise to $392 from $360 and keeps an Underweight rating on the shares. ahead of the Q1 report. There is near-term volatility to life insurance company earnings from variable investment income headwinds and commentary around spread income peaking, but valuations “are generally not screening as overly optimistic,” the analyst tells investors in a research note.